Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2026-01-01 @ 1:46 AM
Study NCT ID:
NCT01129206
Status:
COMPLETED
Last Update Posted:
2016-06-01
First Post:
2010-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OSU-10018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None